yahoo_financeOriginal article
Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes
Data ReadoutpositiveRoxadustatPositive
AI Analysis
Summary
Kyntra Bio presented new clinical data showing roxadustat improved transfusion independence in patients with anemia due to lower-risk myelodysplastic syndromes, with benefits observed across different ring sideroblast statuses.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
Roxadustat demonstrated improvements in transfusion independence regardless of ring sideroblast status in patients with anemia due to lower-risk myelodysplastic syndromes
Importance:6/10
Sentiment:
0.70
roxadustatmyelodysplastic syndromesanemiatransfusion independenceclinical data
Related Companies
Read the original article
Published by yahoo_finance on June 11, 2026 8:05 PM